Incyte (INCY) Enterprise Value (2010 - 2026)
Incyte's Enterprise Value came in at $18.25 billion for Q2 2026, up 69.0% from $10.8 billion a year earlier and up 23.3% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Enterprise Value (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Incyte reported Enterprise Value of $7.72 billion, up 73.1% year-over-year; for FY2025, it was $16.02 billion, up 43.0% from FY2024.
- Enterprise Value carries a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $11.2 billion in FY2024 (+7.4%), $10.43 billion in FY2023 (-28.8%), $14.65 billion in FY2022 (+5.6%) and $13.88 billion in FY2021 (-19.7%).
- The Q2 2026 figure represents the highest quarterly Enterprise Value since Q2 2020.
- Year-over-year, Enterprise Value has increased for eight consecutive quarters, with growth averaging 28.7% over the last eight quarters.
- The fastest year-over-year change in Enterprise Value over five years came in Q2 2026 (growth of 69.0%), and the weakest in Q1 2024 (a decline of 31.3%).
- Business Quant data shows INCY's Enterprise Value at $14.8 billion (Q1 2026), $16.02 billion (Q4 2025) and $13.7 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Incyte | 25.09 Bn | 10.02 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.25 Bn |
| Mar 31, 2026 | 14.80 Bn |
| Dec 31, 2025 | 16.02 Bn |
| Sep 30, 2025 | 13.70 Bn |
| Jun 30, 2025 | 10.80 Bn |
| Mar 31, 2025 | 9.32 Bn |
| Dec 31, 2024 | 11.20 Bn |
| Sep 30, 2024 | 10.97 Bn |
| Jun 30, 2024 | 10.16 Bn |
| Mar 31, 2024 | 8.94 Bn |
| Dec 31, 2023 | 10.43 Bn |
| Sep 30, 2023 | 9.43 Bn |
| Jun 30, 2023 | 10.48 Bn |
| Mar 31, 2023 | 13.01 Bn |
| Dec 31, 2022 | 14.65 Bn |
| Sep 30, 2022 | 11.85 Bn |
| Jun 30, 2022 | 14.13 Bn |
| Mar 31, 2022 | 15.04 Bn |
| Dec 31, 2021 | 13.88 Bn |
| Sep 30, 2021 | 12.91 Bn |
API Access
Incyte Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();